ALS issues in clinical trials. Missing data

Affiliations

Review

John L P Thompson et al. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004 Sep.

. 2004 Sep:5 Suppl 1:48-51.

doi: 10.1080/17434470410019753.

¹ Statistical Analysis Center (SAC), Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY, USA. jlt12@columbia.edu

No abstract available

Cited by

Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III.
Kaufmann P, Thompson JL, Levy G, Buchsbaum R, Shefner J, Krivickas LS, Katz J, Rollins Y, Barohn RJ, Jackson CE, Tiryaki E, Lomen-Hoerth C, Armon C, Tandan R, Rudnicki SA, Rezania K, Sufit R, Pestronk A, Novella SP, Heiman-Patterson T, Kasarskis EJ, Pioro EP, Montes J, Arbing R, Vecchio D, Barsdorf A, Mitsumoto H, Levin B; QALS Study Group. Kaufmann P, et al. Ann Neurol. 2009 Aug;66(2):235-44. doi: 10.1002/ana.21743. Ann Neurol. 2009. PMID: 19743457 Free PMC article. Clinical Trial.
Web-based data management for a phase II clinical trial in ALS.
Buchsbaum R, Kaufmann P, Barsdorf AI, Arbing R, Montes J, Thompson JL; QALS Study Group. Buchsbaum R, et al. Amyotroph Lateral Scler. 2009 Oct-Dec;10(5-6):374-7. doi: 10.3109/17482960802378998. Amyotroph Lateral Scler. 2009. PMID: 19922127 Free PMC article.
Methodological Quality of Clinical Trials in Amyotrophic Lateral Sclerosis: A Systematic Review.
Pupillo E, Al-Chalabi A, Sassi S, Arippol E, Tinti L, Vitelli E, Copetti M, Leone MA, Bianchi E. Pupillo E, et al. J Neuromuscul Dis. 2024;11(4):749-765. doi: 10.3233/JND-230217. J Neuromuscul Dis. 2024. PMID: 38759021 Free PMC article.